Hemogenyx Pharmaceuticals Plc

LSE (GBp): Hemogenyx Pharmaceuticals Plc (HEMO)

Last Price

862.00

Today's Change

-148.00 (14.65%)

Day's Change

800.00 - 1,040.00

Trading Volume

58,049

Profile
HEMO

Exchange: 

Currency:  GBp GBp

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO: 

Full Time Employees: 

IPO Date: 

CIK: 

ISIN: 

CUSIP: 

Beta: 

Last Dividend: 

Dcf Diff: 

Dcf: 

Description

Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. It is involved in developing products for bone marrow/hematopoietic stem cell (BM/HSC) transplant market, including CDX bi-specific antibody targeting relapsed/refractory acute myeloid leukaemia (R/R AML), subset of acute lymphoblastic leukaemia, and myelodysplastic syndrome conditioning bone marrow transplants to substitute traditional chemotherapy and/or radiation; HEMO-CAR-T therapy, a chimeric antigen receptor T-cells to identify and destroy human AML-derived cells in vitro and in vivo; and Human Postnatal Hematopoietic Endothelial Cells, a stem cell therapy product for BM/HSC transplants. The company was founded in 2012 and is headquartered in London, the United Kingdom.

Address

http://www.hemogenyx.com

Discussions
Be the first to like this. Showing 0 of 0 comments

{uid}

{comment}

Just now

Post a Comment